UNLIMITED TURBO BULL - AMGEN | Real-time Euronext Paris 03:38:58 2024-05-29 am EDT | ||
| 10.8 EUR | -0.64% |
|
| Current month | +25.81% | ||
| 1 month | +32.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 10.8 | -0.64% |
| 24-05-28 | 10.87 | -5.56% |
| 24-05-27 | 11.51 | +0.26% |
| 24-05-24 | 11.48 | -2.63% |
| 24-05-23 | 11.79 | -2.32% |
Real-time Euronext Paris
Last update May 29, 2024 at 03:38 am EDT
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| 8C37S | |
| ISIN | DE000SU96G03 |
| Date issued | 2024-03-04 |
| Strike | 182.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.79 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.62 € |
|---|---|
| Lowest since issue | 7.5 € |
| Spread | 0.15 € |
| Spread % | 1.38% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- 8C37S Certificat
